keyword
MENU ▼
Read by QxMD icon Read
search

Pharmacare

keyword
https://www.readbyqxmd.com/read/27744279/universal-prescription-drug-coverage-in-canada-long-promised-yet-undelivered
#1
REVIEW
Steven G Morgan, Katherine Boothe
Canada's universal public healthcare system is unique among developed countries insofar as it does not include universal coverage of prescription drugs. Universal, public coverage of prescription drugs has been recommended by major national commissions in Canada dating back to the 1960s. It has not, however, been implemented. In this article, we extend research on the failure of early proposals for universal drug coverage in Canada to explain failures of calls for reform over the past 20 years. We describe the confluence of barriers to reform stemming from Canadian policy institutions, ideas held by federal policy-makers, and electoral incentives for necessary reforms...
November 2016: Healthcare Management Forum
https://www.readbyqxmd.com/read/27577437/a-digital-health-system-to-assist-family-physicians-to-safely-prescribe-noac-medications
#2
Samina Raza Abidi, Jafna Cox, Ashraf Abusharekh, Nima Hashemian, Syed Sibte Raza Abidi
Atrial Fibrillation (AF) is the most common cardiac arrhythmia. Generally, the therapeutic options for managing AF include the use of anticoagulant drugs that prevent the coagulation of blood. New Oral Anticoagulants (NOACs) are not optimally prescribed to patients, despite their efficacy. In Canada, NOAC medications are not directly available to patients who belong to provincial benefits programs, rather a NOAC special authorization process establishes the eligibility of a patient to receive a NOAC and be paid by the provincial Pharmacare program...
2016: Studies in Health Technology and Informatics
https://www.readbyqxmd.com/read/27434392/trends-in-statin-use-in-seniors-1999-to-2013-time-series-analysis
#3
Laura V Minard, Amber Corkum, Ingrid Sketris, Judith Fisher, Ying Zhang, Ahmed Saleh
PURPOSE: To examine HMG-CoA reductase inhibitor (statin) drug dispensing patterns to Nova Scotia Seniors' Pharmacare program (NSSPP) beneficiaries over a 14-year period in response to: 1) rosuvastatin market entry in 2003, 2) JUPITER trial publication in 2008, and 3) generic atorvastatin availability in 2010. METHODS: All NSSPP beneficiaries who redeemed at least one prescription for a statin from April 1, 1999 to March 31, 2013 were included. Aggregated, anonymous monthly prescription counts were extracted by the Nova Scotia Department of Health and Wellness (Nova Scotia, Canada) and changes in dispensing patterns of statins were measured...
2016: PloS One
https://www.readbyqxmd.com/read/27412200/national-pharmacare-time-to-move-forward
#4
Leila Salehi
No abstract text is available yet for this article.
July 2016: Canadian Family Physician Médecin de Famille Canadien
https://www.readbyqxmd.com/read/26464141/election-2015-new-arguments-for-pharmacare
#5
Lauren Vogel
No abstract text is available yet for this article.
October 13, 2015: CMAJ: Canadian Medical Association Journal, Journal de L'Association Medicale Canadienne
https://www.readbyqxmd.com/read/26445589/what-canadians-are-saying-about-pharmacare
#6
(no author information available yet)
No abstract text is available yet for this article.
September 2015: Canadian Pharmacists Journal: CPJ, Revue des Pharmaciens du Canada: RPC
https://www.readbyqxmd.com/read/26445588/pharmacare-2-0-aims-to-reboot-national-pharmacare-conversation
#7
(no author information available yet)
No abstract text is available yet for this article.
September 2015: Canadian Pharmacists Journal: CPJ, Revue des Pharmaciens du Canada: RPC
https://www.readbyqxmd.com/read/25947034/use-of-compassionate-supply-of-antiretroviral-drugs-to-avoid-treatment-interruptions-or-delayed-treatment-initiation-among-hiv-positive-patients-living-in-ontario-a-retrospective-review
#8
Deborah Yoong, Mark Naccarato, Kevin Gough, Jordan Lewis, Ahmed M Bayoumi
BACKGROUND: Without a national pharmacare plan in Canada, HIV-infected patients across the nation differ in their ability to obtain essential HIV therapy. Despite the fact there are public insurance programs in Ontario, patients are unable to access medication. The authors described how frequently patients in their urban clinic could not access medications and why they required a compassionate supply of HIV drugs, with the goals of minimizing treatment delays and avoiding interruptions...
February 2015: Healthcare Policy, Politiques de Santé
https://www.readbyqxmd.com/read/25838573/redressing-the-inequities-in-canadian-pharmacare
#9
D Wayne Taylor
Canadian healthcare is not universal. Nowhere is this lack of universality more evident than in the payment for drugs in Canada. Canadians without the financial wherewithal cannot access orphan drugs for rare diseases and take-at-home oral cancer drugs and many other pharmaceuticals. In addition to the physical and emotional tolls experienced, patients and survivors and their families and caregivers bear the brunt of an ever-growing financial burden. This article outlines how this happened and what to do about it...
March 2015: Healthcare Management Forum
https://www.readbyqxmd.com/read/25802314/canada-can-afford-universal-pharmacare-%C3%A2-no-more-excuses
#10
EDITORIAL
Matthew B Stanbrook
No abstract text is available yet for this article.
April 21, 2015: CMAJ: Canadian Medical Association Journal, Journal de L'Association Medicale Canadienne
https://www.readbyqxmd.com/read/25780047/estimated-cost-of-universal-public-coverage-of-prescription-drugs-in-canada
#11
Steven G Morgan, Michael Law, Jamie R Daw, Liza Abraham, Danielle Martin
BACKGROUND: With the exception of Canada, all countries with universal health insurance systems provide universal coverage of prescription drugs. Progress toward universal public drug coverage in Canada has been slow, in part because of concerns about the potential costs. We sought to estimate the cost of implementing universal public coverage of prescription drugs in Canada. METHODS: We used published data on prescribing patterns and costs by drug type, as well as source of funding (i...
April 21, 2015: CMAJ: Canadian Medical Association Journal, Journal de L'Association Medicale Canadienne
https://www.readbyqxmd.com/read/25498311/reforming-private-drug-coverage-in-canada-inefficient-drug-benefit-design-and-the-barriers-to-change-in-unionized-settings
#12
Sean O'Brady, Marc-André Gagnon, Alan Cassels
Prescription drugs are the highest single cost component for employees' benefits packages in Canada. While industry literature considers cost-containment for prescription drug costs to be a priority for insurers and employers, the implementation of cost-containment measures for private drug plans in Canada remains more of a myth than a reality. Through 18 semi-structured phone interviews conducted with experts from private sector companies, unions, insurers and plan advisors, this study explores the reasons behind this incapacity to implement cost-containment measures by examining how private sector employers negotiate drug benefit design in unionized settings...
February 2015: Health Policy
https://www.readbyqxmd.com/read/24883162/increased-health-service-utilization-costs-in-the-year-prior-to-institutionalization-findings-from-the-canadian-study-of-health-and-aging
#13
John A Naslund, Agnes H Sauter, Gloria Gutman, B Lynn Beattie
OBJECTIVES: The objective of this study was to characterize patterns of formal health service utilization costs during older adults' transition from community to institutional care. METHODS: Participants were 127 adults (age ≥ 65) from the British Columbia sample (N = 2,057) of the Canadian Study of Health and Aging who transitioned from community to institutional care between 1991 and 2001. Health service utilization costs were measured using Cost-Per-Day-At-Risk at five time points: > 12 months, 6-12 months, and ≤ 6 months preinstitutionalization, and ≤ 6 months and 6-12 months postinstitutionalization...
June 2014: Canadian Geriatrics Journal: CGJ
https://www.readbyqxmd.com/read/24711215/framing-incremental-expansions-to-public-health-insurance-systems-the-case-of-canadian-pharmacare
#14
Jamie R Daw, Steven G Morgan, Patricia A Collins, Julia Abelson
Canada is the only country in the world to offer universal comprehensive public health insurance that excludes outpatient prescription medicines. Few scholars have attempted to explain this policy puzzle. We study media coverage of prescription drug financing from 1990 to 2010 to elucidate how the policy problem and potential solutions have been framed in media discourse and identify the actors that have dominated media texts. We confirm previous analyses that have revealed the significant role played by policy elites in media coverage of health reform debates...
April 2014: Journal of Health Politics, Policy and Law
https://www.readbyqxmd.com/read/23968600/canadian-pharmacare-looking-back-looking-forward
#15
Steven G Morgan, Jamie R Daw
Despite Canadians' pride in medicare and the values underpinning it, the system is conspicuously incomplete. Universal public health insurance in Canada ends as soon as a patient is handed a prescription to fill; yet prescription drugs are the second largest component of health system costs. We look back at key moments in Canadian healthcare history that shaped our pharmacare system - or lack thereof. We look forward to changes in demography and technology that will increase the need for pharmacare reform in the near future...
August 2012: Healthcare Policy, Politiques de Santé
https://www.readbyqxmd.com/read/23890157/prescribing-trends-of-antipsychotics-in-youth-receiving-income-assistance-results-from-a-retrospective-population-database-study
#16
Andrea L Murphy, David M Gardner, Charmaine Cooke, Steve Kisely, Jean Hughes, Stan P Kutcher
BACKGROUND: Prescribing of antipsychotics (AP) to young people has increased in the last decade internationally. We aimed to characterize AP prescribing in a population of low-income youth in Nova Scotia, Canada. METHODS: We conducted a population database study of AP prescription claims and health services utilization by young people aged 25 years and younger receiving drug benefits through the publicly funded Pharmacare program between October 1, 2000 to September 30, 2007...
2013: BMC Psychiatry
https://www.readbyqxmd.com/read/23559528/differences-in-utilisation-of-gastroprotective-drugs-between-2001-and-2005-in-australia-and-nova-scotia-canada
#17
MULTICENTER STUDY
Susan E Tett, Ingrid Sketris, Charmaine Cooke, Sander Veldhuyzen van Zanten, Nadia Barozzi
PURPOSE: This study aimed to compare use of histamine H2 receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), 2001-2005, in the elderly and social security beneficiaries in Australia (AUS) and Nova Scotia, Canada (NS). METHODS: Prescription dispensing data were collected for all subsidised H2RAs and PPIs. In AUS, dispensing data for concession beneficiaries were obtained from the Pharmaceutical Benefits Scheme database. In NS, data were sourced from the Pharmacare database...
July 2013: Pharmacoepidemiology and Drug Safety
https://www.readbyqxmd.com/read/23110682/public-preferences-for-government-spending-in-canada
#18
Sabrina Ramji, Carlos Quiñonez
This study considers three questions: 1. What are the Canadian public's prioritization preferences for new government spending on a range of public health-related goods outside the scope of the country's national system of health insurance? 2. How homogenous or heterogeneous is the Canadian public in terms of these preferences? 3. What factors are predictive of the Canadian public's preferences for new government spending? Data were collected in 2008 from a national random sample of Canadian adults through a telephone interview survey (n=1,005)...
2012: International Journal for Equity in Health
https://www.readbyqxmd.com/read/22574760/government-spending-on-dental-care-is-it-a-public-priority
#19
Sabrina Ramji, Carlos Quiñonez
OBJECTIVES: The majority of Canadians believe that the government should play some role in providing dental care within Canada's health care system. However, it is unclear whether Canadians consider this as a top public priority. This study determines whether dental care is a public priority among Canadian adults relative to other policy concerns and identifies factors predictive of a first priority ranking for dental care. METHODS: Data were collected in 2008 from a national random sample of 1,005 Canadian adults through a telephone interview survey...
2012: Journal of Public Health Dentistry
https://www.readbyqxmd.com/read/22529401/effect-of-misalignment-between-hospital-and-provincial-formularies-on-medication-discrepancies-at-discharge-ppits-proton-pump-inhibitor-therapeutic-substitution-study
#20
Doson Chua, Eric Chu, Angela Lo, Melissa Lo, Fruzina Pataky, Linda Tang, Ajay Bains
BACKGROUND: Medication discrepancies may occur on admission, transfer, or discharge from hospital. Therapeutic interchange within a drug class is a common practice in hospitals, and orders for specific proton pump inhibitors (PPIs) are often substituted with the hospital's formulary PPI through therapeutic interchange protocols. Rabeprazole is the PPI on the formulary of the British Columbia PharmaCare program. However, different PPIs may appear on the formularies of the province's hospitals...
March 2012: Canadian Journal of Hospital Pharmacy
keyword
keyword
41916
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"